RNAI modulation of the Rho-A gene and uses thereof

Details for Australian Patent Application No. 2010206007 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Soutschek, Juergen; Tan, Pamela; Geick, Anke; Vornlocher, Hans-Peter

Agent Griffith Hack

Pub. Number AU-B-2010206007

Parent 2006272808

Filing date 27 July 2010

Wipo publication date 19 August 2010

Acceptance publication date 8 December 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

19 August 2010 Application Open to Public Inspection

  Published as AU-B-2010206007

19 August 2010 Complete Application Filed

8 December 2011 Application Accepted

  Published as AU-B-2010206007

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010206008-Apparatus and method for administering a therapeutic agent

2010205984-Hybrid-driven cold/heat storage type heat pump unit utilizing solar photovoltaic power and commercial power